Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Dupilumab in Children with Uncontrolled Moderate-to-Severe Asthma
Leonard B. Bacharier, Jorge Máspero, Constance H. Katelaris, et al.
New England Journal of Medicine (2021) Vol. 385, Iss. 24, pp. 2230-2240
Open Access | Times Cited: 74

Showing 1-25 of 74 citing articles:

Heterogeneity of type 2 innate lymphoid cells
Hergen Spits, Jenny Mjösberg
Nature reviews. Immunology (2022) Vol. 22, Iss. 11, pp. 701-712
Open Access | Times Cited: 98
Interleukins 4 and 13 in Asthma: Key Pathophysiologic Cytokines and Druggable Molecular Targets
Corrado Pelaia, Enrico Heffler, Claudia Crimi, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 84
Human germline heterozygous gain-of-functionSTAT6variants cause severe allergic disease
Mehul Sharma, Daniel Leung, Mana Momenilandi, et al.
The Journal of Experimental Medicine (2023) Vol. 220, Iss. 5
Open Access | Times Cited: 63
GEMA 5.3. Spanish Guideline on the Management of Asthma
Vicente Plaza, Isam Alobid, Cesáreo Álvarez Rodríguez, et al.
Open Respiratory Archives (2023) Vol. 5, Iss. 4, pp. 100277-100277
Open Access | Times Cited: 62
T helper 2 cells in asthma
James A. Harker, Clare M. Lloyd
The Journal of Experimental Medicine (2023) Vol. 220, Iss. 6
Open Access | Times Cited: 57
Cytokine-targeted therapies for asthma and COPD
Florence Schleich, Nicolas Bougard, Catherine Moermans, et al.
European Respiratory Review (2023) Vol. 32, Iss. 168, pp. 220193-220193
Open Access | Times Cited: 38
New insights into the pathophysiology and therapeutic targets of asthma and comorbid chronic rhinosinusitis with or without nasal polyposis
Ilja Střı́ž, Korneliusz Golebski, Zuzana Střížová, et al.
Clinical Science (2023) Vol. 137, Iss. 9, pp. 727-753
Open Access | Times Cited: 33
Type 2 inflammation and biological therapies in asthma: Targeted medicine taking flight
Imran Howell, Aleksandra Howell, Ian Pavord
The Journal of Experimental Medicine (2023) Vol. 220, Iss. 7
Open Access | Times Cited: 28
Pathobiology of Type 2 Inflammation in Asthma and Nasal Polyposis
Corrado Pelaia, Giulia Pelaia, Angelantonio Maglio, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 10, pp. 3371-3371
Open Access | Times Cited: 27
Dupilumab leads to better-controlled asthma and quality of life in children: the VOYAGE study
Alessandro Fiocchi, Wanda Phipatanakul, Robert S. Zeiger, et al.
European Respiratory Journal (2023) Vol. 62, Iss. 5, pp. 2300558-2300558
Open Access | Times Cited: 21
Blood Eosinophils for Prediction of Exacerbation in Preschool Children With Recurrent Wheezing
Anne M. Fitzpatrick, Jocelyn R. Grunwell, Kirsten A. Cottrill, et al.
The Journal of Allergy and Clinical Immunology In Practice (2023) Vol. 11, Iss. 5, pp. 1485-1493.e8
Open Access | Times Cited: 19
Severe Asthma and Biological Therapies: Now and the Future
Olaia Sardón, Carolina Díaz‐García, Paula Corcuera, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 18, pp. 5846-5846
Open Access | Times Cited: 18
The Role of Biologics in the Treatment of Food Allergy
Sayantani Sindher, Alessandro Fiocchi, Torsten Zuberbier, et al.
The Journal of Allergy and Clinical Immunology In Practice (2023) Vol. 12, Iss. 3, pp. 562-568
Closed Access | Times Cited: 18
Biologic Therapies for Asthma and Allergic Disease: Past, Present, and Future
Fernando Ramírez-Jiménez, Gandhi F. Pavón-Romero, Juancarlos Manuel Velásquez-Rodríguez, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 2, pp. 270-270
Open Access | Times Cited: 17
The Role of Eosinophil-Derived Neurotoxin and Vascular Endothelial Growth Factor in the Pathogenesis of Eosinophilic Asthma
Maciej Tota, Julia Łacwik, Julia Laska, et al.
Cells (2023) Vol. 12, Iss. 9, pp. 1326-1326
Open Access | Times Cited: 16
Living without eosinophils: evidence from mouse and man
David J. Jackson, Ian Pavord
European Respiratory Journal (2022) Vol. 61, Iss. 1, pp. 2201217-2201217
Open Access | Times Cited: 22
Novel Biological Therapies for Severe Asthma Endotypes
Corrado Pelaia, Giulia Pelaia, Claudia Crimi, et al.
Biomedicines (2022) Vol. 10, Iss. 5, pp. 1064-1064
Open Access | Times Cited: 21
Biologic Therapies in Pediatric Asthma
Evanthia Perikleous, Paschalis Steiropoulos, Evangelia Nena, et al.
Journal of Personalized Medicine (2022) Vol. 12, Iss. 6, pp. 999-999
Open Access | Times Cited: 19
Efficacy, safety, and tolerability of lebrikizumab in adolescent patients with uncontrolled asthma (ACOUSTICS)
Stanley J. Szefler, Graham Roberts, Adalberto Sperb Rubin, et al.
Clinical and Translational Allergy (2022) Vol. 12, Iss. 7
Open Access | Times Cited: 19
Blockade of STAT3/IL-4 overcomes EGFR T790M-cis-L792F-induced resistance to osimertinib via suppressing M2 macrophages polarization
Yiting Sun, Yiting Dong, Xijuan Liu, et al.
EBioMedicine (2022) Vol. 83, pp. 104200-104200
Open Access | Times Cited: 19
Association between Dupilumab and Conjunctivitis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Tzu‐Yi Lin, Ching-Ya Wang, Fang‐Ying Wang, et al.
Pharmaceutics (2023) Vol. 15, Iss. 4, pp. 1031-1031
Open Access | Times Cited: 11
Unanswered questions on the use of biologics in pediatric asthma
Antonio Nieto, Zeinab A. El-Sayed, René Maximiliano Gómez, et al.
World Allergy Organization Journal (2023) Vol. 16, Iss. 11, pp. 100837-100837
Open Access | Times Cited: 11
Medication-related perceptions of children and adolescents with severe asthma and moderate-to-severe atopic dermatitis: a non-interventional exploratory study
Markus Herzig, Maike vom Hove, Astrid Bertsche, et al.
Allergy Asthma and Clinical Immunology (2025) Vol. 21, Iss. 1
Open Access
Targeting IL-13 and IL-4 in Asthma: Therapeutic Implications on Airway Remodeling in Severe Asthma
Lina Sahnoon, Khuloud Bajbouj, Bassam Mahboub, et al.
Clinical Reviews in Allergy & Immunology (2025) Vol. 68, Iss. 1
Open Access
Role of Chemokines and Inflammatory Cells in Respiratory Allergy
Youwei Bao, Xinhua Zhu
Journal of Asthma and Allergy (2022) Vol. Volume 15, pp. 1805-1822
Open Access | Times Cited: 17
Page 1 - Next Page

Scroll to top